0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Respiratory Diseases Diagnostic Testing - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-28C5885
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Respiratory Diseases Diagnostic Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Respiratory Diseases Diagnostic Testing - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-28C5885
Report
November 2023
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Respiratory Diseases Diagnostic Testing - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Respiratory Diseases Diagnostic Testing -  Market

Respiratory Diseases Diagnostic Testing - Market

Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases
The global Respiratory Diseases Diagnostic Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Respiratory Diseases Diagnostic Testing in various end use industries. The expanding demands from the Hospitals, Physician Clinics, Clinical Laboratories and Others, are propelling Respiratory Diseases Diagnostic Testing market. Imaging Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Respiratory Measurement segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Respiratory Diseases Diagnostic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Respiratory Diseases Diagnostic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Respiratory Diseases Diagnostic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Respiratory Diseases Diagnostic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Respiratory Diseases Diagnostic Testing covered in this report include Philips Healthcare, BD, Abbott, Thermo Fisher Scientific, Roche, ResMed, Fischer & Paykel, Medtronic and MGC Diagnostics, etc.
The global Respiratory Diseases Diagnostic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Philips Healthcare
BD
Abbott
Thermo Fisher Scientific
Roche
ResMed
Fischer & Paykel
Medtronic
MGC Diagnostics

Scope of Respiratory Diseases Diagnostic Testing - Market Report

Report Metric Details
Report Name Respiratory Diseases Diagnostic Testing - Market
CAGR 5%
Global Respiratory Diseases Diagnostic Testing market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Respiratory Diseases Diagnostic Testing market, Segment by Type:
  • Imaging Test
  • Respiratory Measurement
  • Blood Gas Test
  • Other
Global Respiratory Diseases Diagnostic Testing market, by Application
  • Hospitals
  • Physician Clinics
  • Clinical Laboratories
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Respiratory Diseases Diagnostic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the Respiratory Diseases Diagnostic Testing - Market report?

Ans: The Applications covered in the Respiratory Diseases Diagnostic Testing - Market report are Hospitals, Physician Clinics, Clinical Laboratories, Others

What are the Type segmentation covered in the Respiratory Diseases Diagnostic Testing - Market report?

Ans: The Types covered in the Respiratory Diseases Diagnostic Testing - Market report are Imaging Test, Respiratory Measurement, Blood Gas Test, Other

1 Market Overview of Respiratory Diseases Diagnostic Testing
1.1 Respiratory Diseases Diagnostic Testing Market Overview
1.1.1 Respiratory Diseases Diagnostic Testing Product Scope
1.1.2 Respiratory Diseases Diagnostic Testing Market Status and Outlook
1.2 Global Respiratory Diseases Diagnostic Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Respiratory Diseases Diagnostic Testing Market Size by Region (2018-2029)
1.4 Global Respiratory Diseases Diagnostic Testing Historic Market Size by Region (2018-2023)
1.5 Global Respiratory Diseases Diagnostic Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Respiratory Diseases Diagnostic Testing Market Size (2018-2029)
1.6.1 North America Respiratory Diseases Diagnostic Testing Market Size (2018-2029)
1.6.2 Europe Respiratory Diseases Diagnostic Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size (2018-2029)
1.6.4 Latin America Respiratory Diseases Diagnostic Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size (2018-2029)
2 Respiratory Diseases Diagnostic Testing Market by Type
2.1 Introduction
2.1.1 Imaging Test
2.1.2 Respiratory Measurement
2.1.3 Blood Gas Test
2.1.4 Other
2.2 Global Respiratory Diseases Diagnostic Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Respiratory Diseases Diagnostic Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Respiratory Diseases Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Respiratory Diseases Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Respiratory Diseases Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue Breakdown by Type (2018-2029)
3 Respiratory Diseases Diagnostic Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Physician Clinics
3.1.3 Clinical Laboratories
3.1.4 Others
3.2 Global Respiratory Diseases Diagnostic Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Respiratory Diseases Diagnostic Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Respiratory Diseases Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Respiratory Diseases Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Respiratory Diseases Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue Breakdown by Application (2018-2029)
4 Respiratory Diseases Diagnostic Testing Competition Analysis by Players
4.1 Global Respiratory Diseases Diagnostic Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Diseases Diagnostic Testing as of 2022)
4.3 Date of Key Players Enter into Respiratory Diseases Diagnostic Testing Market
4.4 Global Top Players Respiratory Diseases Diagnostic Testing Headquarters and Area Served
4.5 Key Players Respiratory Diseases Diagnostic Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Respiratory Diseases Diagnostic Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Philips Healthcare
5.1.1 Philips Healthcare Profile
5.1.2 Philips Healthcare Main Business
5.1.3 Philips Healthcare Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.1.4 Philips Healthcare Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Philips Healthcare Recent Developments
5.2 BD
5.2.1 BD Profile
5.2.2 BD Main Business
5.2.3 BD Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.2.4 BD Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.2.5 BD Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.3.4 Abbott Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.5.4 Roche Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 ResMed
5.6.1 ResMed Profile
5.6.2 ResMed Main Business
5.6.3 ResMed Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.6.4 ResMed Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.6.5 ResMed Recent Developments
5.7 Fischer & Paykel
5.7.1 Fischer & Paykel Profile
5.7.2 Fischer & Paykel Main Business
5.7.3 Fischer & Paykel Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.7.4 Fischer & Paykel Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Fischer & Paykel Recent Developments
5.8 Medtronic
5.8.1 Medtronic Profile
5.8.2 Medtronic Main Business
5.8.3 Medtronic Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.8.4 Medtronic Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Medtronic Recent Developments
5.9 MGC Diagnostics
5.9.1 MGC Diagnostics Profile
5.9.2 MGC Diagnostics Main Business
5.9.3 MGC Diagnostics Respiratory Diseases Diagnostic Testing Products, Services and Solutions
5.9.4 MGC Diagnostics Respiratory Diseases Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.9.5 MGC Diagnostics Recent Developments
6 North America
6.1 North America Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Respiratory Diseases Diagnostic Testing Market Dynamics
11.1 Respiratory Diseases Diagnostic Testing Industry Trends
11.2 Respiratory Diseases Diagnostic Testing Market Drivers
11.3 Respiratory Diseases Diagnostic Testing Market Challenges
11.4 Respiratory Diseases Diagnostic Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Respiratory Diseases Diagnostic Testing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Respiratory Diseases Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Respiratory Diseases Diagnostic Testing Market Size Share by Region (2018-2023)
    Table 4. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Respiratory Diseases Diagnostic Testing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Respiratory Diseases Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2018-2023)
    Table 9. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2024-2029)
    Table 11. North America Respiratory Diseases Diagnostic Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Respiratory Diseases Diagnostic Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Respiratory Diseases Diagnostic Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Respiratory Diseases Diagnostic Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Respiratory Diseases Diagnostic Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Respiratory Diseases Diagnostic Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Respiratory Diseases Diagnostic Testing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Respiratory Diseases Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2018-2023)
    Table 24. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2024-2029)
    Table 26. North America Respiratory Diseases Diagnostic Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Respiratory Diseases Diagnostic Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Respiratory Diseases Diagnostic Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Respiratory Diseases Diagnostic Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Respiratory Diseases Diagnostic Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Respiratory Diseases Diagnostic Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Respiratory Diseases Diagnostic Testing Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Respiratory Diseases Diagnostic Testing as of 2022)
    Table 39. Date of Key Players Enter into Respiratory Diseases Diagnostic Testing Market
    Table 40. Global Respiratory Diseases Diagnostic Testing Key Players Headquarters and Area Served
    Table 41. Respiratory Diseases Diagnostic Testing Product Solution and Service
    Table 42. Global Respiratory Diseases Diagnostic Testing Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Philips Healthcare Basic Information List
    Table 45. Philips Healthcare Description and Business Overview
    Table 46. Philips Healthcare Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of Philips Healthcare (2018-2023)
    Table 48. Philips Healthcare Recent Developments
    Table 49. BD Basic Information List
    Table 50. BD Description and Business Overview
    Table 51. BD Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of BD (2018-2023)
    Table 53. BD Recent Developments
    Table 54. Abbott Basic Information List
    Table 55. Abbott Description and Business Overview
    Table 56. Abbott Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of Abbott (2018-2023)
    Table 58. Abbott Recent Developments
    Table 59. Thermo Fisher Scientific Basic Information List
    Table 60. Thermo Fisher Scientific Description and Business Overview
    Table 61. Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of Thermo Fisher Scientific (2018-2023)
    Table 63. Thermo Fisher Scientific Recent Developments
    Table 64. Roche Basic Information List
    Table 65. Roche Description and Business Overview
    Table 66. Roche Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of Roche (2018-2023)
    Table 68. Roche Recent Developments
    Table 69. ResMed Basic Information List
    Table 70. ResMed Description and Business Overview
    Table 71. ResMed Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of ResMed (2018-2023)
    Table 73. ResMed Recent Developments
    Table 74. Fischer & Paykel Basic Information List
    Table 75. Fischer & Paykel Description and Business Overview
    Table 76. Fischer & Paykel Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of Fischer & Paykel (2018-2023)
    Table 78. Fischer & Paykel Recent Developments
    Table 79. Medtronic Basic Information List
    Table 80. Medtronic Description and Business Overview
    Table 81. Medtronic Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of Medtronic (2018-2023)
    Table 83. Medtronic Recent Developments
    Table 84. MGC Diagnostics Basic Information List
    Table 85. MGC Diagnostics Description and Business Overview
    Table 86. MGC Diagnostics Respiratory Diseases Diagnostic Testing Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Respiratory Diseases Diagnostic Testing Business of MGC Diagnostics (2018-2023)
    Table 88. MGC Diagnostics Recent Developments
    Table 89. North America Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 90. North America Respiratory Diseases Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 91. Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 92. Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 93. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 94. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 95. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2024-2029) & (US$ Million)
    Table 96. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Share by Region (2018-2023)
    Table 97. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Share by Region (2024-2029)
    Table 98. Latin America Respiratory Diseases Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 99. Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 100. Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 101. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 102. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 103. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 104. Respiratory Diseases Diagnostic Testing Market Trends
    Table 105. Respiratory Diseases Diagnostic Testing Market Drivers
    Table 106. Respiratory Diseases Diagnostic Testing Market Challenges
    Table 107. Respiratory Diseases Diagnostic Testing Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Respiratory Diseases Diagnostic Testing Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Respiratory Diseases Diagnostic Testing Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Respiratory Diseases Diagnostic Testing Market Share by Regions: 2022 VS 2029
    Figure 4. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Imaging Test
    Figure 11. Global Imaging Test Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Respiratory Measurement
    Figure 13. Global Respiratory Measurement Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Blood Gas Test
    Figure 15. Global Blood Gas Test Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Other
    Figure 17. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Global Respiratory Diseases Diagnostic Testing Market Size Share by Type: 2022 & 2029
    Figure 19. North America Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2018-2029)
    Figure 20. Europe Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2018-2029)
    Figure 21. Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2018-2029)
    Figure 22. Latin America Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2018-2029)
    Figure 23. Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2018-2029)
    Figure 24. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Physician Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 26. Clinical Laboratories Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 27. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 28. Global Respiratory Diseases Diagnostic Testing Market Size Share by Application: 2022 & 2029
    Figure 29. North America Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2018-2029)
    Figure 30. Europe Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2018-2029)
    Figure 31. Asia-Pacific Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2018-2029)
    Figure 32. Latin America Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2018-2029)
    Figure 33. Middle East and Africa Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2018-2029)
    Figure 34. Respiratory Diseases Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 35. Global Top 5 and Top 10 Players Respiratory Diseases Diagnostic Testing Market Share in 2022
    Figure 36. North America Respiratory Diseases Diagnostic Testing Market Share by Country (2018-2029)
    Figure 37. U.S. Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 38. Canada Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 39. Germany Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 40. France Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 41. U.K. Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 42. Italy Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 43. Russia Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 44. Nordic Countries Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 45. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Share by Region (2018-2029)
    Figure 46. China Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 47. Japan Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 48. South Korea Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 49. Southeast Asia Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 50. India Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 51. Australia Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 52. Latin America Respiratory Diseases Diagnostic Testing Market Share by Country (2018-2029)
    Figure 53. Mexico Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 54. Brazil Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 55. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Share by Country (2018-2029)
    Figure 56. Turkey Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 57. Saudi Arabia Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 58. UAE Respiratory Diseases Diagnostic Testing Market Size (2018-2029) & (US$ Million)
    Figure 59. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Respiratory Assist Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-30T8247
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Bronchiolitis Obliterans Syndrome Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5U5938
Thu Feb 22 00:00:00 UTC 2024

Add to Cart

Global Table Type Spirometer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-15D7711
Thu Feb 22 00:00:00 UTC 2024

Add to Cart

Global Non-Cystic Fibrosis Bronchiectasis Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-30S5649
Thu Feb 22 00:00:00 UTC 2024

Add to Cart